Special 301 presents an analysis of the efforts that Indonesia has made for intellectual property rights awareness and enforcement through the IPR Working Group under the United States-Indonesia Trade and Investment Framework Agreement. Despite these positive touches, the US review states that they are not effective and as a result, there is an increase in Internet piracy and counterfeiting pharmaceutical products. US expect from Indonesia more efficient and transparent judicial and prosecutorial system that could permit adequate fight against piracy and counterfeiting. Hereby a synthesis of the IPR issues for Indonesia: “the need of effective system for protecting against the unfair commercial use, as well as unauthorized disclosure, of undisclosed test or other data generated to obtain marketing approval for pharmaceutical and agricultural chemical products, market access barriers in Indonesia, including measures that appear to condition permissions to import medicines on at least partial local manufacturing or technology transfer requirements, importation of motion pictures, Indonesian patent law not requirring individual merits review in connection with the grant of compulsory licenses, need of providing judicial or other independent review of any compulsory license authorizations.”
The entire report can be found here.
